InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Browse the detailed record of transactions filed by Boehnlein Glenn S, Chief Financial Officer. Director active across 2 companies, notably STRYKER CORP. Aggregated, 7 disclosures have been logged. Total volume traded: €205k. The latest transaction was disclosed on 8 June 2022 — Attribution. Regulator: SEC (Form 4). All data is openly available.
Declarations7 total
06,849 shares0
Common Stock
SEC:0001209191-22-036046:0·
01,210 shares0
Common Stock
SEC:0000310764-22-000066:0·
0459 shares0
Common Stock
SEC:0001209191-22-021026:0·
08,723 shares0
Common Stock
SEC:0000310764-22-000049:0·
0170 shares0
Common Stock
SEC:0000310764-22-000038:0·
€102,507447 shares@ €229.32280.0001% mcap100.0% of flow
Common Stock
SEC:0000310764-21-000156·
€102,507447 shares@ €229.32280.0001% mcap50.0% of flow
Common Stock
SEC:0000310764-21-000156:0·
7 of 7 declarations
About Boehnlein Glenn S
Glenn S. Boehnlein serves as Vice President and Chief Financial Officer of Stryker Corp and Inogen Inc. In this role, he is responsible for the financial management of the companies, including budgeting and financial analysis. Glenn plays a key role in developing financial strategies that support the growth and profitability of the businesses. His expertise in finance is essential for the success of Stryker and Inogen.
